Gordon M. Binder - 15 Jun 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Gordon M. Binder by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
15 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 16:10:54 UTC
Previous filing
06 Sep 2022
Next filing
15 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +8,500 $0.000000 8,500 15 Jun 2023 Common Stock 8,500 $3.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027.